A.M. Etingof
EFFICACY AND SAFETYOF TERALIGEN IN ROUTINE PRACTICE
|
8-13 |
K.E. Fedorov (1), T.A. Sergienko (2), S.S. Golubev (3), E.V. Atyasova (4), N.A. Nazarova (2), S.V. Moiseev (5), P.I. Novikov (1)
PRIMARY Β-AMYLOID-ASSOCIATED CENTRAL NERVOUS SYSTEM VASCULITIS
|
14-20 |
I.B. Belyaeva (1), A.L. Chudinov (1, 2), V.I. Mazurov (1), T.G. Shemerovskaya (2)
MODERN VIEW ON THE PROBLEM OF DRUG THERAPY OF ANCA-ASSOCIATED SYSTEMIC VASCULITIDES
|
21-24 |
A.G. Merkin (1, 2), A.N. Komarov (2), V.A. Kazhin (3), E.N. Dinov (4), O.P. Beloskurskaya (4), S.V. Kosyaeva (2), D.A. Simolina (2), P.V. Aronov (1), A.S. Bychkova (1), L.P. Kezina (2), I.A. Nikiforov (1)
DEMENTIA AND MILD COGNITIVE IMPAIRMENT (DIFFERENTIAL EVALUATION AND THERAPY)
|
26-29 |
N.A. Shamalov (1, 2), K.V. Anisimov (1), M.A. Kustova (2), A.P. Tolmachev (2), V.V. Biryukov (3)
THROMBOLYTIC THERAPY FOR ISCHEMIC STROKE: PREDICTORS OF SAFETY AND EFFICACY
|
30-35 |
N.V. Chichasova, G.R. Imametdinova
CURRENT TREATMENT OF RHEUMATOID ARTHRITIS: RECOMMENDATIONS AND ACTUAL PRACTICE
|
36-42 |
T.P. Shevtsova (1), P.I. Novikov (2), I.O. Smitienko (3), A.D. Meshkov (4), S.V. Moiseev (4)
EFFICACY OF IMMUNOSUPPRESSIVE AND ANTICOAGULANT THERAPY FOR THE GRANULOMATOSIS PATIENT WITH WITH POLYANGIITIS AND CRYOFIBRINOGENEMIA
|
43-47 |
O.A. Gromova (1, 2), I.Yu. Torshin (2, 3), S.E. Maligin (4), O.A. Limanova (1, 2), A.V. Gilels (5)
ON THE ANTI-TUMOR EFFECT OF VITAMIN D3: FUNDAMENTAL RESEARCH AND EVIDENCE-BASED MEDICINE
|
48-58 |
S.V.Tarasova, MD, M.A.Kurapov
EXPERIENCE OF THE USE OF THIOCTIC ACID IN COMPLEX TREATMENT OF PATIENTS WITH MULTIPLE SCLEROSIS EXACERBATIONS
|
59-63 |
G.V. Rodoman (1, 2), T.I .Shalaeva (1, 2), E.K. Naumov (1, 2), E.E. Naumova (2)
COMPARATIVE ANALYSIS OF DIFFERENT METHODS OF SURGICAL TREATMENT OF VARICOSE VEIN DISEASE OF THE LOWER EXTREMITIES IN CHRONIC VENOUS INSUFFICIENCY
|
64-67 |
M.A. Domashenko, M.A. Loskutnikov, M.E. Gafarova, M.Yu. Maksimova
INTRACRANIAL ATHEROSCLEROSIS: CLINICAL MANIFESTATIONS AND APPROACHES TO THE TREATMENT
|
68-73 |
S.V. Popov
ERECTILE DYSFUNCTION AGAINST THE BACKGROUND OF CENTRAL NERVOUS SYSTEM DISEASES
|
74-79 |